Description
THIS PRODUCT IS ONLY AVAILABLE FOR PATIENTS OF DR. SHAW. IF YOU ARE NOT A PATIENT AND YOU PLACE AN ORDER, YOU WILL BE REFUNDED THE FULL AMOUNT MINUS THE FEE CHARGED BY THE WEBSITE FOR PLACING THE ORDER.
TestoQuench™ for Women, provided by Douglas Laboratories® is a Hormone Specific Formulation™ of antiandrogens and androgen antagonists. This combination is designed to support the healthy function of skin, hair, heart, breasts, vagina and other testosterone sensitive tissues in women.
Hormone Specific Formulation™ provided by Douglas Laboratories® and formulated by Dr Joseph J Collins, is
created to support the optimal function of specific hormones through the use of hormone specific adaptogens,
hormone specific agonists and hormone specific functional mimetics. This formulation may be used to as part
of a hormone health program with dietary and nutrient support. In addition, this formulation may be used by
clinicians as an adjuvant to support optimal hormone health in patients who have been prescribed bioidentical
hormone therapies.
TestoQuench™ for Women is a synergistic combination of phytoantiandrogens designed to restore healthy
hormone balance by calming and supporting the ideal function of testosterone sensitive tissues.
Phytoantiandrogens are a class of phyto-compounds that decrease tissue sensitivity to androgens or decrease
androgen activity, predominantly through the action of 5-alpha-reductase inhibition, which decreases
conversion of testosterone to the more androgenic dihydrotestosterone.
The synergistic combination of specific herbs in TestoQuench™ support important functions associated with
optimal testosterone health in women:
• Restore and promote normal, healthy androgen functions
• Supports healthy blood lipid levels†
• Promotes healthy immune function†
• Helps normalize the function of skin, heart, breasts, brain and other tissues sensitive to testosterone†
• Supports healthy brain function, memory, and cognition, enhances mood while promoting tranquility†
Reviews
There are no reviews yet.